摘要
本文从"B型钠酸肽"检查项目的原理、效用出发,纵向比较2010年以来顺义区定点医疗机构以该项目申报医疗保险支付费用增长情况,横向比较该项目申报类别分布,按医院级别、费用发生类别进行统计分析,并结合诊断分析是否存在该项目过度使用情况。结果 :顺义区"B型钠酸肽"项目费用申报逐年显著增加,整体门诊费用发生较多,不同医疗机构发生情况不同,二、三级医院费用申报占主体,诊断相关性较差。
From the perspective of principle and utility, this paper made a longitudinal comparison of the increased insurance cost of B-type natriuretic peptide declared in designated medical institutions of Shunyi District since 2010, and a cross-sectional analysis of its distribution. The statistical analyses were conducted according to hospital level and expenses types, and the situation of over-use this project was evaluated based on diagnosis. Results: B-type natriuretic peptide cost in Shunyi District was increased significantly year by year, and the cost in outpatient department was higher than that in inpatient department. The situations varied in different medical institutions, the cost were dominantly occurred in secondary and tertiary hospital with poor diagnosis-associated relationship.
作者
解锡海
付秀梅
管卫勇
Xie Xihai Fu Xiumei Guan Weiyong(Social Insurance Management Center of Shunyi District, Beijing, 101300)
出处
《中国医疗保险》
2017年第2期46-48,共3页
China Health Insurance
关键词
B型钠酸肽
费用组成分析
相关性分析
B-type natriuretic peptide, cost composition analysis, association analysis